Hims vs Navio MD
Navio MD costs $10 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →
Navio MD
Best for: moving between compounded and brand without changing seller
Visit Navio MD →If you are choosing between Hims and Navio MD, the first difference is cost: Navio MD is $10 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Navio MD leads our six-part score, 8.2 to 6.8. One of the two has an FDA warning letter on record, covered below.
Hims vs Navio MD price
Navio MD is the cheaper way in: $189 a month against $199 a month at Hims. That is $10 less each month (5% lower), or about $120 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Hims ($199 a month vs $345 a month); tirzepatide is cheaper at Navio MD ($189 a month vs $299 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format they match: each offers compounded injections and brand-name pens.
Where each one treats patients
Hims lists 50 states, and Navio MD lists 48 states.
They overlap in 48 states. Hims alone covers Alabama and Mississippi.
Pricing
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
Navio MD
as low as $189/mo; tiered by dose
as low as $345/mo; brand price varies by dose
as low as $445/mo; tiered by dose
as low as $1,249/mo; tiered by dose
Ozempic as low as $345/mo (compounded tirzepatide $189/mo also offered)
What each price covers
Hims' price also covers the medication itself, which Navio MD does not claim.
Hims is silent on shipping and lab work.
Navio MD does not say what its price includes.
That matters most for the drug: unless Navio MD confirms otherwise, budget for medication on top of its listed price.
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Navio MD
Inclusions not disclosed.
Where each one scores higher
Overall, Navio MD scores 8.2 and Hims 6.8 out of 10.
Navio MD is stronger on value (7.0 vs 3.0), trust & safety (8.5 vs 7.0) and support (5.0 vs 3.0).
Effectiveness, user experience and accessibility are within half a point.
Hims
6.8/10
Navio MD
8.2/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
Navio MD has no FDA warning letter on record with us.
Features & Coverage
| Feature | Hims | Navio MD |
|---|---|---|
| Starting Price | $199/mo | ✓$189/mo |
| Features | 2 features | ✓6 features |
| States Available | ✓50 | 48 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →About Navio MD
NavioMD sells compounded tirzepatide at $247/mo plus brand-name Ozempic at $1,199/mo and Mounjaro at $1,249/mo. It is LegitScript verified and available in 48 states, not AL or MS. The price is the same at every dose. It also offers women's hormone optimization.
Read our full Navio MD review →Pros & Cons
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Navio MD
What we like
- Tirzepatide costs $189 a month, 24% below the $250 median for compounded tirzepatide across the sellers we compare
- Semaglutide costs $345 a month, 65% below the $997 median for brand-name semaglutide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- Serves 48 states
- We found no FDA warning letters issued to Navio MD
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its tirzepatide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Navio MD wins this one, 8.2 to 6.8, above all for moving between compounded and brand without changing seller. It also costs $10 less each month than Hims. Hims fits better if knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC is your priority.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Choose Navio MD if…
You want moving between compounded and brand without changing seller and an opening price near $189 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
bmiMD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Eden
Coverage in all 50 states, which most sellers will not confirm
From $239/mo
Get started →SnagRx
Semaglutide at $99/month, 48% below the typical price
From $99/mo
Get started →Hims vs Navio MD: FAQ
Close alternatives to Hims and Navio MD
- Hims vs Hers
- Hims vs Care Bare Rx
- Hims vs Concierge MD LA
- Hims vs Corsica Health
- Navio MD vs Eve
- Navio MD vs Hers
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.